Filing Details

Accession Number:
0000899243-19-022005
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-19 08:35:30
Reporting Period:
2019-08-16
Accepted Time:
2019-08-19 08:35:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1466301 Clovis Oncology Inc. CLVS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1266569 J Patrick Mahaffy C/o Clovis Oncology, Inc.
5500 Flatiron Parkway, Suite 100
Boulder CO 80301
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-16 400 $5.56 919,187 No 4 P Direct
Common Stock Acquisiton 2019-08-16 400 $5.58 919,587 No 4 P Direct
Common Stock Acquisiton 2019-08-16 3,706 $5.57 923,293 No 4 P Direct
Common Stock Acquisiton 2019-08-16 2,100 $5.61 925,393 No 4 P Direct
Common Stock Acquisiton 2019-08-16 6,400 $5.61 931,793 No 4 P Direct
Common Stock Acquisiton 2019-08-16 11,314 $5.58 943,107 No 4 P Direct
Common Stock Acquisiton 2019-08-16 3,700 $5.59 946,807 No 4 P Direct
Common Stock Acquisiton 2019-08-16 11,053 $5.59 957,860 No 4 P Direct
Common Stock Acquisiton 2019-08-16 5,100 $5.60 962,960 No 4 P Direct
Common Stock Acquisiton 2019-08-16 5,827 $5.60 968,787 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000 Indirect By son
Common Stock 1,000 Indirect By daughter
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.